Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-01-03 @ 9:17 AM
Study NCT ID:
NCT00392769
Status:
COMPLETED
Last Update Posted:
2012-09-06
First Post:
2006-10-25
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Cetuximab in Patients With Progressive or Recurrent Endometrial Cancer
Sponsor:
M.D. Anderson Cancer Center
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Endometrial Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Endometrial Cancer | View |
| None | Progressive or Recurrent Endometrial Cancer | View |
| None | Cetuximab | View |
| None | C225 | View |
| None | Erbitux™ | View |
| None | IMC-C225 | View |
| None | Epidermal growth factor receptor | View |
| None | EGFR | View |
| None | Endometrioid Tumor | View |
| None | Serous Tumor | View |
| None | Clear cell Tumor | View |
| None | Mixed malignant Mullerian Tumors | View |